Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Coulter Pharmaceuticals, Inc. (now GSK)

Coulter was a South San Francisco-based biopharmaceutical company specializing in cancer therapeutics. The company was acquired by Seattle-based Corixa Corporation in 2000.

Search Projects

  • Vice President, Quality and Compliance
  • Vice President, Regulatory Affairs